Company profile

Ticker
ONTX
Exchange
CEO
Steven M. Fruchtman
Employees
Incorporated in
Location
Fiscal year end
Former names
Onconova Therapeutics Inc
SEC CIK

ONTX stock data

(
)

Calendar

14 Aug 19
24 Aug 19
31 Dec 19

News

Company financial data Financial data

Quarter (USD) Jun 19 Mar 19 Dec 18 Sep 18
Revenue 2.02M 68K 59K 120K
Net income -3.56M -7.6M -5.65M -5.35M
Diluted EPS -0.6 -1.29 -0.85 -0.94
Net profit margin -176% -11176% -9578% -4457%
Operating income -3.63M -7.24M -6.15M -5.59M
Cash on hand
Annual (USD) Dec 18 Dec 17 Dec 16 Dec 15
Revenue 1.23M 787K 5.55M 11.46M
Net income -20.57M -24.09M -19.67M -23.98M
Diluted EPS -4.99 -40.15 -4.44 -10.54
Net profit margin -1675% -3061% -355% -209%
Operating income -23.28M -25.74M -23.7M -23.97M
Net change in cash 1.6M -23.78M
Cash on hand 21.4M 19.8M

Financial data from company earnings reports

Financial report summary

?
Competition
G1 Therapeutics
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: Abundant, addressing, al, attaining, azacitdine, conclusion, daily, deadline, forward, guarantee, journal, LR, mutated, notification, recovered, rhabdomyosarcoma, spending, TI, uncertain, withheld
Removed: authoritative, launch, melanoma, recipient, rendered, reviewed, studying, vest